308 related articles for article (PubMed ID: 9566594)
1. Cannabinoid receptors and their endogenous agonist, anandamide.
Axelrod J; Felder CC
Neurochem Res; 1998 May; 23(5):575-81. PubMed ID: 9566594
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid ligand-receptor signaling in the mouse uterus.
Das SK; Paria BC; Chakraborty I; Dey SK
Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
[TBL] [Abstract][Full Text] [Related]
3. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.
Di Marzo V; Bisogno T; De Petrocellis L; Melck D; Martin BR
Curr Med Chem; 1999 Aug; 6(8):721-44. PubMed ID: 10469888
[TBL] [Abstract][Full Text] [Related]
4. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
5. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
Paria BC; Ma W; Andrenyak DM; Schmid PC; Schmid HH; Moody DE; Deng H; Makriyannis A; Dey SK
Biol Reprod; 1998 Jun; 58(6):1490-5. PubMed ID: 9623610
[TBL] [Abstract][Full Text] [Related]
6. Cannabis: discrimination of "internal bliss"?
Wiley JL
Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
[TBL] [Abstract][Full Text] [Related]
7. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
[TBL] [Abstract][Full Text] [Related]
8. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
[TBL] [Abstract][Full Text] [Related]
9. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.
Di Marzo V
Biochim Biophys Acta; 1998 Jun; 1392(2-3):153-75. PubMed ID: 9630590
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats.
Wiley JL; Ryan WJ; Razdan RK; Martin BR
Eur J Pharmacol; 1998 Aug; 355(2-3):113-8. PubMed ID: 9760024
[TBL] [Abstract][Full Text] [Related]
11. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
Paria BC; Das SK; Dey SK
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9460-4. PubMed ID: 7568154
[TBL] [Abstract][Full Text] [Related]
12. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.
Williams CM; Kirkham TC
Psychopharmacology (Berl); 1999 Apr; 143(3):315-7. PubMed ID: 10353436
[TBL] [Abstract][Full Text] [Related]
13. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
Mallet PE; Beninger RJ
Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid system and cytokine network.
Klein TW; Lane B; Newton CA; Friedman H
Proc Soc Exp Biol Med; 2000 Oct; 225(1):1-8. PubMed ID: 10998193
[TBL] [Abstract][Full Text] [Related]
15. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
Shivachar AC; Martin BR; Ellis EF
Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904
[TBL] [Abstract][Full Text] [Related]
16. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission.
Hampson AJ; Bornheim LM; Scanziani M; Yost CS; Gray AT; Hansen BM; Leonoudakis DJ; Bickler PE
J Neurochem; 1998 Feb; 70(2):671-6. PubMed ID: 9453561
[TBL] [Abstract][Full Text] [Related]
18. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
Facci L; Dal Toso R; Romanello S; Buriani A; Skaper SD; Leon A
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3376-80. PubMed ID: 7724569
[TBL] [Abstract][Full Text] [Related]
19. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats.
Smith FL; Fujimori K; Lowe J; Welch SP
Pharmacol Biochem Behav; 1998 May; 60(1):183-91. PubMed ID: 9610941
[TBL] [Abstract][Full Text] [Related]
20. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.
Felder CC; Nielsen A; Briley EM; Palkovits M; Priller J; Axelrod J; Nguyen DN; Richardson JM; Riggin RM; Koppel GA; Paul SM; Becker GW
FEBS Lett; 1996 Sep; 393(2-3):231-5. PubMed ID: 8814296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
